Your email has been successfully added to our mailing list.

×
-0.0774774774774774 -0.0774774774774774 -0.0774774774774774 -0.0774774774774774 -0.0774774774774774 -0.0774774774774774 -0.0774774774774774 -0.0774774774774774
Stock impact report

Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results

UROVANT SCIENCES LTD COMMON (UROV) 
Last urovant sciences ltd common earnings: 2/13 04:15 pm Check Earnings Report
Company Research Source: Business Wire
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences (Nasdaq: UROV) today reported financial results for the 2019 third fiscal quarter ended December 31, 2019.Recent Business Highlights Submitted a New Drug Application for vibegron for the treatment of patients with overactive bladder to the U.S. Food and Drug Administration (FDA) in December 2019.Initiated a Phase 2a study of URO-902, a novel gene therapy product for patients with overactive bladder that have failed oral pharmacologic therapy.Entered into a $300 million low interest, interest-only, five-year term loan facility with Sumitomo Dainippon Pharma.“This has been an exciting and transformational quarter for our company, marked by key milestones across all aspects of our business,” said Keith A. Katkin, chief executive officer of Urovant Sciences. “We submitted our New Drug Application for vibegron for the treatment of patients with overactive bladder to the FDA ahead of schedule, initiated a Phase 2a st Show less Read more
Impact Snapshot
Event Time:
UROV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for UROV alerts
Opt-in for
UROV alerts

from News Quantified
Opt-in for
UROV alerts

from News Quantified